These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 14767284

  • 1. Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy.
    Shariat SF, Khoddami SM, Saboorian H, Koeneman KS, Sagalowsky AI, Cadeddu JA, McConnell JD, Holmes MN, Roehrborn CG.
    J Urol; 2004 Mar; 171(3):1122-7. PubMed ID: 14767284
    [Abstract] [Full Text] [Related]

  • 2. Perineural invasion is a prognostic factor for biochemical failure after radical prostatectomy.
    Jeon HG, Bae J, Yi JS, Hwang IS, Lee SE, Lee E.
    Int J Urol; 2009 Aug; 16(8):682-6. PubMed ID: 19602004
    [Abstract] [Full Text] [Related]

  • 3. Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy.
    Khoddami SM, Shariat SF, Lotan Y, Saboorian H, McConnell JD, Sagalowsky AI, Roehrborn CG, Koeneman KS.
    BJU Int; 2004 Jul; 94(1):42-6. PubMed ID: 15217428
    [Abstract] [Full Text] [Related]

  • 4. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.
    Shariat SF, Abdel-Aziz KF, Roehrborn CG, Lotan Y.
    Eur Urol; 2006 Feb; 49(2):293-302. PubMed ID: 16387412
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progression.
    Loeb S, Roehl KA, Yu X, Antenor JA, Han M, Gashti SN, Yang XJ, Catalona WJ.
    Urology; 2006 Jul; 68(1):99-103. PubMed ID: 16806410
    [Abstract] [Full Text] [Related]

  • 12. Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml.
    Makarov DV, Humphreys EB, Mangold LA, Walsh PC, Partin AW, Epstein JI, Freedland SJ.
    J Urol; 2006 Aug; 176(2):554-8. PubMed ID: 16813888
    [Abstract] [Full Text] [Related]

  • 13. Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin status.
    Masterson TA, Pettus JA, Middleton RG, Stephenson RA.
    Urology; 2005 Jul; 66(1):152-5. PubMed ID: 15992904
    [Abstract] [Full Text] [Related]

  • 14. Significance of perineural invasion, lymphovascular invasion, and high-grade prostatic intraepithelial neoplasia in robot-assisted laparoscopic radical prostatectomy.
    Jung JH, Lee JW, Arkoncel FR, Cho NH, Yusoff NA, Kim KJ, Song JM, Kim SJ, Rha KH.
    Ann Surg Oncol; 2011 Dec; 18(13):3828-32. PubMed ID: 21660497
    [Abstract] [Full Text] [Related]

  • 15. Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?
    Fitzsimons NJ, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ.
    J Urol; 2006 Dec; 176(6 Pt 1):2453-8; discussion 2458. PubMed ID: 17085127
    [Abstract] [Full Text] [Related]

  • 16. Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy.
    Shariat SF, Anwuri VA, Lamb DJ, Shah NV, Wheeler TM, Slawin KM.
    J Clin Oncol; 2004 May 01; 22(9):1655-63. PubMed ID: 15117988
    [Abstract] [Full Text] [Related]

  • 17. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center.
    Freedland SJ, Grubb KA, Yiu SK, Humphreys EB, Nielsen ME, Mangold LA, Isaacs WB, Partin AW.
    J Urol; 2005 Sep 01; 174(3):919-22. PubMed ID: 16093988
    [Abstract] [Full Text] [Related]

  • 18. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    Haukaas SA, Halvorsen OJ, Daehlin L, Hostmark J, Akslen LA.
    BJU Int; 2006 Jan 01; 97(1):51-5. PubMed ID: 16336328
    [Abstract] [Full Text] [Related]

  • 19. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
    Bastian PJ, Gonzalgo ML, Aronson WJ, Terris MK, Kane CJ, Amling CL, Presti JC, Mangold LA, Humphreys E, Epstein JI, Partin AW, Freedland SJ.
    Cancer; 2006 Sep 15; 107(6):1265-72. PubMed ID: 16900523
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.